Álvarez-Fernández, Alejandra
Maggi, Ricardo
Martín-Valls, Gerard Eduard
Baxarias, Marta
Breitschwerdt, Edward Bealmear
Solano-Gallego, Laia http://orcid.org/0000-0001-8479-4896
Funding for this research was provided by:
Elanco Animal Health
Article History
Received: 4 June 2021
Accepted: 18 November 2021
First Online: 4 January 2022
Declarations
:
: This study was conducted according to the guidelines of the Declaration of Helsinki, but ethical review and approval were waived for the study, due to non-invasive procedures and use of residual specimens. Furthermore, a signed consent form was obtained from the owner or the person in charge of the cats.
: The authors declare no conflict of interest. Edward B. Breitschwerdt is a founder, shareholder and chief scientific officer for Galaxy Diagnostics, Research Triangle Park, North Carolina, USA. Galaxy Diagnostics was not involved in any aspect of this study. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.